XML 101 R88.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Business Segments (Details) (USD $) In Thousands, unless otherwise specified | 3 Months Ended | 12 Months Ended
--- | --- | ---
Jun. 30, 2014 | Mar. 31, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2012 | Sep. 30, 2012 | Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2012
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net sales | $ 183,677 | $ 173,267 | $ 172,742 | $ 162,228 | $ 164,201 | $ 162,685 | $ 164,159 | $ 162,106 | $ 691,914 | $ 653,151 | $ 654,101
Adjusted EBITDA | 24,245 | 22,444 | 22,310 | 21,598 | 19,651 | 19,420 | 18,778 | 17,905 | 90,597 | 75,754 |
Depreciation and amortization |  |  |  |  |  |  |  |  | 21,453 | 19,023 | 17,527
Loss on insurance claim | (5,350) |  |  |  |  |  |  |  |  |  |
Foreign currency gains (losses), net | 335 | (275) | (1,165) | (648) | (1,971) | (838) | (126) | (168) | (1,753) | (3,103) | (1,192)
Loss on extinguishment of debt | (22,771) |  |  |  |  |  |  |  | (22,771) |  |
Other income (expense), net |  |  |  |  | 377 | (482) | (58) | 12 |  | (151) | 400
Income before income taxes | (16,143) | 8,303 | 7,134 | 7,014 | 4,337 | 4,266 | 5,017 | 4,228 | 6,308 | 17,848 | 13,114
Identifiable assets | 472,323 |  |  |  | 474,142 |  |  |  | 472,323 | 474,142 |
Animal Health |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net sales | 114,108 | 107,808 | 107,966 | 101,171 | 100,694 | 93,883 | 94,236 | 96,128 | 431,053 | 384,941 |
Adjusted EBITDA | 26,146 | 25,505 | 24,522 | 24,107 | 23,044 | 20,334 | 19,516 | 20,103 | 100,280 | 82,997 |
Mineral Nutrition |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net sales | 54,879 | 49,901 | 50,633 | 46,186 | 48,728 | 51,757 | 52,892 | 49,792 | 201,599 | 203,169 |
Adjusted EBITDA | 3,491 | 2,807 | 2,878 | 2,460 | 2,765 | 3,439 | 3,175 | 2,690 | 11,636 | 12,069 |
Performance Products |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net sales | 14,690 | 15,558 | 14,143 | 14,871 | 14,779 | 17,045 | 17,031 | 16,186 | 59,262 | 65,041 |
Adjusted EBITDA | 1,521 | 906 | 1,103 | 1,096 | (1,621) | 1,577 | 1,826 | 1,145 | 4,626 | 2,927 |
Operating Segments |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net sales |  |  |  |  |  |  |  |  | 691,914 | 653,151 | 654,101
Adjusted EBITDA |  |  |  |  |  |  |  |  | 90,597 | 75,754 | 66,852
Depreciation and amortization |  |  |  |  |  |  |  |  | (21,453) | (19,023) | (17,527)
Loss on insurance claim |  |  |  |  |  |  |  |  | (5,350) |  |
Interest expense, net |  |  |  |  |  |  |  |  | (32,962) | (35,629) | (35,419)
Foreign currency gains (losses), net |  |  |  |  |  |  |  |  | (1,753) | (3,103) | (1,192)
Loss on extinguishment of debt |  |  |  |  |  |  |  |  | (22,771) |  |
Other income (expense), net |  |  |  |  |  |  |  |  |  | (151) | 400
Income before income taxes |  |  |  |  |  |  |  |  | 6,308 | 17,848 | 13,114
Identifiable assets | 472,323 |  |  |  | 474,142 |  |  |  | 472,323 | 474,142 |
Operating Segments | Animal Health |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net sales |  |  |  |  |  |  |  |  | 431,053 | 384,941 | 375,167
Adjusted EBITDA |  |  |  |  |  |  |  |  | 100,280 | 82,997 | 70,456
Identifiable assets | 361,376 |  |  |  | 329,323 |  |  |  | 361,376 | 329,323 |
Operating Segments | Mineral Nutrition |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net sales |  |  |  |  |  |  |  |  | 201,599 | 203,169 | 210,091
Adjusted EBITDA |  |  |  |  |  |  |  |  | 11,636 | 12,069 | 13,007
Identifiable assets | 57,460 |  |  |  | 64,719 |  |  |  | 57,460 | 64,719 |
Operating Segments | Performance Products |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net sales |  |  |  |  |  |  |  |  | 59,262 | 65,041 | 68,843
Adjusted EBITDA |  |  |  |  |  |  |  |  | 4,626 | 2,927 | 5,132
Identifiable assets | 23,429 |  |  |  | 21,233 |  |  |  | 23,429 | 21,233 |
Corporate |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Adjusted EBITDA |  |  |  |  |  |  |  |  | (25,945) | (22,239) | (21,743)
Identifiable assets | $ 30,058 |  |  |  | $ 58,867 |  |  |  | $ 30,058 | $ 58,867 |

X
- Definition Adjusted earnings before interest taxes depreciation and amortization. + References No definition available. + Details
Name: | pahc_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
Namespace Prefix: | pahc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Represent amount of related to gain or loss in connection with settlement of insurance claim. + References No definition available. + Details
Name: | pahc_GainLossOnInsuranceClaim
Namespace Prefix: | pahc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.18) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 12 -Article 7 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 18 -Article 5 + Details
Name: | us-gaap_Assets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 + Details
Name: | us-gaap_DepreciationDepletionAndAmortization
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Aggregate impact of foreign currency derivatives on earnings for the period. Includes impact of foreign currency cash flow hedge ineffectiveness and the ineffectiveness of fair value hedging derivatives and full change in fair value of the foreign currency derivatives not designated as hedging instruments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4A -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5618551-113959 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5624171-113959 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 25 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6886632&loc=d3e76258-113986 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4D -Subparagraph (a)(2) -URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5624177-113959 + Details
Name: | us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 50 -Section 40 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6850294&loc=d3e12317-112629 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 50 -Section 40 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6850294&loc=d3e12355-112629 + Details
Name: | us-gaap_GainsLossesOnExtinguishmentOfDebt
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 10 -Article 5 + Details
Name: | us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The net amount of operating interest income (expense). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.10) -URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 10 -Article 9 + Details
Name: | us-gaap_InterestIncomeExpenseNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 9 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.9) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 + Details
Name: | us-gaap_OtherNonoperatingIncomeExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 + Details
Name: | us-gaap_Revenues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_SegmentReportingInformationLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration